Clariness strengthens its European patient access with acquisition of health platform Mondosano
Published by Joseph Yeomans on 11 March 2025
Hamburg, Germany 11 March 2025 – Clariness today announces its acquisition of Mondosano, a digital health platform. This acquisition provides Clariness, and its customers, access to a larger European patient population, and all Mondosano patients get access to more trials.
Mondosano was founded in 2016 and has developed an extensive patient and health partner network in Germany, which is set to fortify the patient access of Clariness’ patient portal, ClinLife®.
Michael Stadler, CEO and Co-Founder of Clariness, commented, “We’re excited about what this acquisition means for Clariness, but more importantly, what it means for patients. This acquisition is in the interest of accelerating medical research, as ClinLife® and Mondosano will combine resources, significantly boosting our reach, and enrolling even more patients into clinical trials.”
Andreas Arntzen, CEO of Wort & Bild Verlag, stated, “Recognizing the alignment between Mondosano’s mission and Clariness’ expertise, we took the initiative to move forward with this acquisition. Under Clariness’ ownership, their scalable solutions and unrivaled experience will help more patients in Germany access treatments for their conditions.”
The acquisition is part of a wider strategic play from Clariness to streamline patient recruitment across the globe, building upon its acquisition of Viomedo in 2016, a search engine for clinical trials in Germany, which became Clariness’ marketplace solution called ClinLife® Registry, and has since been deployed in 8 additional countries to date.
About Clariness
Clariness provides high-end services across the clinical trial lifecycle, including study feasibility, patient recruitment, and patient retention services, for pharmaceutical companies, contract research organizations (CROs), and study sites across the globe. Dedicated to improving patients’ lives by accelerating the development of medical treatments and therapies, Clariness is the leading expert in global patient recruitment with 20+ years’ experience. Clariness has supported over 1,200 clinical trials worldwide through its market leading patient portal ClinLife®, which is active in 50+ countries, available in 35+ languages, covers 100+ indications, and welcomes 15+ million visitors per year. For more information, visit www.clariness.com and www.clinlife.com.
About ClinLife®
ClinLife® is a patient-friendly digital platform that allows users to browse indications, find matching clinical studies and apply for them via the portal. Different sponsors, sites, CROs and digital health applications list a single study or an entire portfolio of clinical trials on ClinLife®.
About Wort & Bild Verlag
Wort & Bild Verlag, founded in 1955 and headquartered in Baierbrunn, Germany, is a leading publisher specializing in health-related media. They produce widely circulated magazines such as Apotheken Umschau, Senioren Ratgeber, and Diabetes Ratgeber, reaching millions of readers monthly. Their publications are primarily distributed through pharmacies, providing accessible and reliable health information to the public.
Press Contact: Joseph Yeomans, VP Marketing, [email protected]
